CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This research program aims to enhance treatment for heart failure by identifying new therapeutic targets and clinical biomarkers. By integrating proteomic, genomic, and epidemiological data, the project seeks to tailor therapies to individual patients based on their specific heart disease profiles.
Heart failure is a leading cause of morbidity and mortality in the aging European populations.
It is the end-stage of myocardial and valvular disease, arising from loss of viable or functional muscle cells in the heart.
Therapy is complicated by the multitude of causes and comorbidities of heart failure.
New therapeutic targets and clinical biomarkers to individually tailor therapy (‘precision medicine’) are greatly needed.
This research program aims to realize the promise of precision medicine…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
